Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Research Highlights Phase 1 (12 weeks): Reductions between ~2.6% and ~11.3% Phase 2 (48 weeks): Lower-dose groups reached ~9% reductions Higher-dose and titration groups achieved ~20% reductions Control groups saw ~0.4% These outcomes place Eloralintide among the strongest-performing compounds within the amylin-pathway category
If your study requires isolating the effects of just one peptide for a control arm, you should purchase the individual vials rather than the blend
This leads to the major motor symptoms of tremor, bradykinesia, and rigidity, along with postural difficulties, which are classical for PD (Obeso et al., 2017)
doi: 10.2174/0929867329666220801161536
ACS Nano 8 , 47714781 (2014)
- Los posibles efectos secundarios pueden incluir hipoglucemia, hinchazn, dolor en el lugar de la inyeccin y aumento del crecimiento de los tumores, si estn presentes
US$ 20.06
US$ 23.32
US$ 22.50
US$ 28.20